What happened

Médecins Sans Frontières says Ebola is still spreading beyond effective control in the Democratic Republic of the Congo, six months after the outbreak began. Reuters reported its warning on 12 November, when confirmed cases had exceeded 11,000. The charity cited unpaid or untrained staff, fuel shortages and inadequate equipment for handling suspected cases.S3

MSF’s full statement also acknowledges improvements: more diagnostic capacity, expanded isolation and treatment facilities, greater community engagement and the launch of research trials. Its criticism is that those gains have not resolved gaps in the wider response. It called for better oversight and support for frontline personnel.R1

Why it matters

WHO’s 6 November report gives a dated measure of those gaps. Across the preceding fortnight, an average of 86% of identified contacts were followed up daily, below its 95% target. These are people already identified for monitoring; the percentage does not measure how many infections surveillance has missed.R3

MSF reported that only 9% of Ebola patients its teams had treated in Ituri had previously been identified as contacts. That figure concerns its patients in one province, rather than every infection across the country. It illustrates why the charity is questioning the reach of contact tracing.R1

WHO’s director-general said on 11 November that transmission was slowing in some places but new hotspots were emerging elsewhere. He also identified insecurity, displacement, difficult terrain, rain and delayed staff payments as obstacles. WHO did not declare the outbreak controlled.R2

The background

The outbreak involves Bundibugyo virus. WHO says there is no approved vaccine or specific treatment for this Ebola disease, and control depends on finding cases, isolating and caring for patients, tracing contacts and safe burials. Its 6 November report recorded sustained transmission.R3

The absence of an approved specific treatment does not mean patients cannot receive useful care. WHO’s Ebola guidance says early supportive care, including rehydration and treatment of symptoms, improves survival. It describes transmission through contact with infected body fluids or contaminated materials, making infection prevention in healthcare facilities central to the response.R5

What happens next

WHO said on 4 November that expert groups had recommended two Bundibugyo vaccine candidates for the Tumaini trial, subject to national approvals. The trial was already evaluating Ervebo against Bundibugyo. That research is intended to establish effectiveness; its existence does not establish that the products protect against this virus.R4

WHO expected vaccine-trial results in early 2027 and initial treatment findings in the coming months. Separately, its director-general said Congo’s updated response plan runs through January 2027. Neither announcement provided a date by which transmission would end.R4R2